Pharmaceutical Commerce

JUNE 17, 2025

Bridging the Gap Between Strategy and Practice in IDN Partnerships Partha Anbil ; Kamini Anbil June 9th 2025 Article In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).

Insurance Coverage and Processing 52

Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies Pharmaceutical Manufacturing 52

FDA Law Blog: Biosimilars

AUGUST 14, 2024

Gaulkin — Enacted in 2022, the Inflation Reduction Act (IRA) amended the Medicare provisions of the Social Security Act to impose several discount requirements on pharmaceutical manufacturers. On July 31, 2024, CMS published a proposed rule to codify its guidances, with some changes.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Drug Pricing 59

FDA Law Blog: Biosimilars

MAY 30, 2024

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. In United Therapeutics Corporation v.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Hospitals 59

FDA Law Blog: Biosimilars

APRIL 16, 2024

Gaulkin — On April 10, the Fourth Circuit unanimously affirmed a summary judgment ruling for the Centers for Medicare & Medicaid Services (CMS) regarding the agency’s definitions of “line-extension drug” and “new formulation” for purposes of determining rebates that drug manufacturers may owe the Medicaid Drug Rebate Program (MDRP).

Dosage 59

Dosage Pharmaceutical Manufacturing Drug Pricing 59

Express Pharma

NOVEMBER 26, 2024

Integrating IT with pharmaceuticals will further strengthen its role, paving the way for dominance in biologics and biosimilars. The day concluded with the prestigious India Pharma Awards 2024, celebrating outstanding achievements in innovation and excellence within the pharmaceutical industry. With exports nearing $27.84

Packaging 105

Packaging Biosimilars Pharmaceutical Manufacturing Dosage 105

Pharmacy Times

JUNE 4, 2025

The Advanced Technologies Lab will help industry and regulators accelerate the adoption of new technologies that help to mitigate supply chain risks and, where appropriate, establish guidance that supports regulatory predictability, process efficiencies, and faster time to market, all of which can strengthen domestic manufacturing capabilities.

Pharmaceutical Manufacturing 26

Pharmaceutical Manufacturing Pharmacy Technician Compounding Pharmacies Compounding 26

Pharmaceutical Commerce

JUNE 16, 2025

2024 Symposium on Public Health Strategies to Combat Substandard and Falsified Drugs. February 5, 2024. Nicholas Saraceno, Editor November 27th 2024 Podcast Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain. October 24, 2013. Johns Hopkins Bloomberg School of Public Health.

Online Pharmacies 52

Online Pharmacies Communication Hospitals Pharmaceutical Manufacturing 52

Pharmaceutical Commerce

JUNE 16, 2025

A Further Examination of Pharmacy Benefit Managers Nicholas Saraceno, Editor March 29th 2024 Podcast Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Commerce

JUNE 13, 2025

It is fair to say that the pharmacy benefit managers (PBMs) enabled it, but pharmaceutical manufacturers took advantage of it. The research firm 46brooklyn did a nice summary of the average price increases from 2012 to 2024 (see chart below), and you can clearly see the shift in behavior from the height of the bubble growth in 2019.

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Pharmaceutical Manufacturing Biosimilars 52

Pharmacy Times

JUNE 12, 2025

A 2024 RAND study using 2022 data found that among Organisation for Economic Co-operation and Development (OECD) countries (comparably developed nations), the US paid 4.22 A 2024 RAND study using 2022 data found that among Organisation for Economic Co-operation and Development (OECD) countries (comparably developed nations), the US paid 4.22

Pharmacy Technician 26

Pharmacy Technician Community Pharmacies Drug Pricing Hospitals 26

Safe Biologics

MARCH 10, 2025

Dr. Christina Beato: Lowering Interchangeable Biosimilar Standards Risks Patient Health, Physician Confidence On January 17th, the Albuquerque Journal published an op-ed by Dr. Christina Beato, former Assistant Secretary for Health and Human Services (HHS) on the topic of interchangeable biosimilar standards.

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130